Understanding the of Hepatitis B Virus Reactivation After Rituximab Withdrawal: Clinical Risks, Delayed Effects, and Preventive Strategies
1 May 2026 Punjab Khabarnama Bureau : The risk of Hepatitis B virus (HBV) reactivation after the withdrawal of rituximab therapy is emerging as a critical concern in modern clinical…